Regeneron Pharmaceuticals, Inc.
Key Metrics
Market Snapshot
About
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for serious diseases. Its marketed products include Eylea for retinal diseases, Dupixent for atopic dermatitis and asthma, Libtayo for skin cancer, and Praluent for cholesterol management, developed using its proprietary VelocImmune antibody technology.